|
Market Closed -
Australian S.E.
08:57:27 06/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0350 AUD | 0.00% |
|
-28.57% | -62.37% |
| 10-08 | Noxopharm Says US FDA Feedback Supports Planned Phase II Trial Approach for Autoimmune Drug Candidate | MT |
| 09-30 | Noxopharm Limited Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 11.69M 8.04M 7.21M 6.59M 6.02M 11.34M 756M 79.45M 31.68M 403M 30.18M 29.53M 1.27B | P/E 2025 |
-3.23x | P/E 2026 | -5.8x |
|---|---|---|---|---|---|
| Enterprise Value | 15.97M 10.98M 9.85M 9M 8.22M 15.48M 1.03B 109M 43.27M 551M 41.23M 40.34M 1.74B | EV / Sales 2025 |
5.92x | EV / Sales 2026 | 21.7x |
| Free-Float |
68.25% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 week | -28.57% | ||
| Current month | -28.57% | ||
| 1 month | -40.68% | ||
| 3 months | -60.23% | ||
| 6 months | -50.00% | ||
| Current year | -62.37% |
| 1 week | 0.03 |  | 0.05 |
| 1 month | 0.03 | | 0.06 |
| Current year | 0.03 | | 0.11 |
| 1 year | 0.03 | | 0.11 |
| 3 years | 0.03 | | 0.15 |
| 5 years | 0.03 | | 0.5 |
| 10 years | 0.03 | | 1.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Olivier Laczka
CEO | Chief Executive Officer | - | 15/04/2026 |
| Director of Finance/CFO | - | 01/03/2019 | |
Lara Babich
PRN | Corporate Officer/Principal | - | 01/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
CHM | Chairman | 70 | 15/03/2016 |
Boris Patkin
BRD | Director/Board Member | - | 26/03/2020 |
Fred Bart Bart
CHM | Chairman | 71 | 09/09/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/09/23 | Buy | Chairman | 880 | 0.0003% | ||
| 17/09/23 | Buy | Chairman | 253,001 | 0.0866% | ||
| 03/07/23 | Buy | Chairman | 135,281 | 0.0463% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -28.57% | -65.00% | -68.18% | 8.14M | |
| -4.83% | +2.88% | +55.87% | +69.12% | 69.4B | |
| +0.02% | +1.42% | +12.77% | +75.21% | 57.24B | |
| -1.34% | +3.53% | +23.22% | +101.58% | 57.62B | |
| +2.62% | -1.17% | +29.37% | +37.84% | 43.65B | |
| +5.09% | +9.53% | +26.62% | +121.44% | 44.03B | |
| +8.24% | +1.06% | +224.03% | +767.69% | 38.08B | |
| -1.86% | +11.46% | +26.67% | +61.40% | 36.31B | |
| -2.97% | -6.89% | +91.79% | +74.60% | 32.61B | |
| -2.18% | +5.68% | +36.21% | -0.69% | 25.47B | |
| Average | +0.28% | +2.01% | +46.16% | +124.00% | 40.44B | |
| Weighted average by Cap. | +0.05% | +2.44% | +53.94% | +138.05% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 2.82M 1.94M 1.74M 1.59M 1.45M 2.73M 182M 19.17M 7.64M 97.3M 7.28M 7.12M 307M | 1.43M 982K 880K 805K 734K 1.38M 92.27M 9.7M 3.87M 49.23M 3.68M 3.61M 155M |
| Net income | -4.88M -3.36M -3.01M -2.75M -2.51M -4.73M -316M -33.18M -13.23M -168M -12.61M -12.34M -532M | -4.46M -3.06M -2.75M -2.51M -2.29M -4.32M -288M -30.27M -12.07M -154M -11.5M -11.25M -485M |
| Net Debt | 925K 636K 571K 521K 476K 897K 59.79M 6.28M 2.51M 31.9M 2.39M 2.34M 101M | 4.28M 2.94M 2.64M 2.41M 2.2M 4.15M 277M 29.08M 11.59M 148M 11.05M 10.81M 466M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | A$0.0350 | 0.00% | 546,819 |
| 05/11/26 | A$0.0350 | -2.78% | 1,518,548 |
| 04/11/26 | A$0.0360 | -25.00% | 942,642 |
- Stock Market
- Stocks
- NOX Stock
Select your edition
All financial news and data tailored to specific country editions
